Lucidome Bio raises $9M for methane vaccine development in livestock, backed by Bezos Earth Fund and agricultural partners.
Amount Raised
$9 Million
Round Type
Venture
AucklandBiotechnologyInvestors
Description
Lucidome Bio has secured $9 million in funding to advance its methane vaccine designed for grazing livestock, particularly cattle and sheep in pasture-based systems. The round includes support from existing investors such as the Bezos Earth Fund, Meat & Livestock Australia, AgriZeroNZ, and the New Zealand Agricultural Greenhouse Gas Research Centre. Funding will support further research and cattle trials beginning over the next 18 months. The Auckland-based company is developing a vaccine targeting methanogenic archaea to reduce methane emissions without affecting animal health or productivity.
Quick answer
Lucidome Bio raised $9 Million in a funding round, dated November 11, 2026. Investors: New Zealand Agricultural Greenhouse Gas Research Centre, AgriZeroNZ, Meat & Livestock Australia and Bezos Earth Fund. Lucidome Bio is based in Auckland, Auckland, New Zealand.
- How much did Lucidome Bio raise?
- Lucidome Bio raised $9 Million in a funding round on November 11, 2026.
- Who invested in Lucidome Bio?
- New Zealand Agricultural Greenhouse Gas Research Centre, AgriZeroNZ, Meat & Livestock Australia and Bezos Earth Fund are named as investors in this round.
- What does Lucidome Bio do?
- Lucidome Bio is a biotechnology company focused on developing a revolutionary methane-reducing vaccine for livestock.
- Where is Lucidome Bio based and how big is it?
- Lucidome Bio is based in Auckland, Auckland, New Zealand.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Lucidome Bio that raised within 45 days of this round, from Fundz verified event records.
- Efferon raised $4.8M (Seed) on November 10, 2026.
- Nanopath raised $25M (Series B) on November 10, 2026.
- Oyster Therapeutics raised $60M (Series A) on November 10, 2026.
- Neobe raised $6.8M on November 10, 2026.
- MyoWorks raised an undisclosed amount on November 10, 2026.
- EnVision Endoscopy raised $12M (Series A) on November 10, 2026.
Who to call at Lucidome Bio, and when
A new round usually means Lucidome Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lucidome Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lucidome Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lucidome Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lucidome Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Lucidome Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.